Navigation Links
UltraLink Immobilized NeutrAvidin from Pierce Biotechnology, Inc.

ProductsUltraLink Immobilized NeutrAvidin from Pierce Biotechnology, Inc.
Company Pierce Biotechnology, Inc.
Item UltraLink Immobilized NeutrAvidin
Price 
Description When nonspecific binding is a problem in your application, Pierce offers a variety of immobilized NeutrAvidin products as superior alternatives to avidin or streptavidin. NeutrAvidin is a modified avidin derivative that combines several key features to provide a biotin-binding protein with exceptionally low nonspecific binding properties. NeutrAvidin does not contain carbohydrate and has an ideal isoelectric point (6.3) for the best utility in a variety of applications.

For assay development, Pierce has coated NeutrAvidin onto microplates and pre-blocked the plastic surface. Any biotinylated compound can now be attached to the plate and analyzed further. Proteins will retain their structural integrity when bound to a protein instead of bound directly to a plastic surface. The plastic surface may distort the structure of the proteins and prevent accurate detection of the ligand in the assay system. Binding biotinylated compounds to NeutrAvidin provides a stable anchor to the plastic surface.
Applications

  • Immunoprecipitation
  • Binding Biotinylated DNA to coated plates
  • Purifying proteins that bind to biotinylated ligands
Features
  • Carbohydrate Free - Just like streptavidin, NeutrAvidin has no carbohydrate, eliminating nonspecific binding problems due to sugars.
  • No interaction with cell surface molecules - absence of the Arg-Tyr-Asp sequence (present in streptavidin), which mimics the universal cell surface recognition sequence present in a variety of molecules, eliminates cross-reactivity of cell surface molecules.
  • Easily conjugated - Most modified avidins have lysines that are unavailable for coupling. NeutrAvidin's unique preparation preserves lysines, making conjugations easier.
  • Neutral pI - With a pI of 6.3, NeutrAvidin's pI is closer to neutrality than avidin or streptavidin. This eliminates electrostatic interaction which contributes to nonspecific binding.
Less nonspecific binding produces better results and better yields.
Info Pierce Biotechnology, Inc.Pierce Biotechnology, Inc.
Pierce Biotechnology, Inc.
3747 N. Meridian Rd.
P.O. Box 117
Rockford, IL 61105
Customer Service: 815-968-0747
Fax Number: 815-968-8148
Web Site: http://www.piercenet.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Immobilized Metal affinity ProteinChip Arrays from Ciphergen
2. Immobilized E. coli Lysate from Pierce Biotechnology, Inc.
3. Modern Protein Chemistry: Practical Aspects from Pierce Biotechnology, Inc.
4. Protein-Protein Interactions, from Pierce Biotechnology, Inc.
5. Imject Freunds Complete Adjuvant (FCA) from Pierce Biotechnology, Inc.
6. Imject Freunds Incomplete Adjuvant (FIA) from Pierce Biotechnology, Inc.
7. Extracti-Gel D Detergent Removing Gel AffinityPak Columns from Pierce Biotechnology, Inc.
8. GUIDE TO PROTEIN PURIFICA from Pierce Biotechnology, Inc.
9. PROTEIN PROTOCOLS Book from Pierce Biotechnology, Inc.
10. Product Information Request - SuperSignal West Pico COMPLETE Biotinylated Protein Detection Kit from Pierce Biotechnology, Inc.
11. DISCOVERLIGHT RABBIT ARRA from Pierce Biotechnology, Inc.
(Date:6/2/2016)... LONDON , June 2, 2016 ... Systems, Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & ... intelligence provider visiongain offers comprehensive analysis of ... that this market will generate revenues of $17.98 billion ... Systems acquired DVTEL Inc, a leader in software and ...
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... services, but it also plays a fundamental part in enabling ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published ... how a patient who developed lymphedema after being treated for breast cancer benefitted from ... the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the ... Convention Center and will showcase its product’s latest features from June 26 to ... a scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
Breaking Biology Technology: